Stock News

3 Stocks to Buy as Cities Reopen
CORRECTED-KKR, Ampersand Capital in joint bid for Oxford Immunotec -sources
Quest Sees Q2 EPS In Range Of Breakeven To Profitable On Testing Volume Recovery
Quest Diagnostics sees faster-than-expected recovery in U.S. testing volumes
Quest expects Q2 adj. EPS of breakeven to slightly profitable if testing trends continue to recover from pandemic
Hedge Funds Have Never Been More Bullish On Quest Diagnostics Incorporated (DGX)
Quest’s Covid-19 Self-Collection Test Kit Gets FDA Nod For Emergency Use
Quest Diagnostics to Speak at the Jefferies Virtual Healthcare Conference
Home State Health and Quest Diagnostics Team Up to Increase Access to COVID-19 Testing in Underserved Communities
Quest's shares rise as FDA authorizes its at-home COVID-19 test
FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use
Coronavirus latest: Wednesday, May 27
Quest Diagnostics launches workforce testing for coronavirus

As seen on...